CSE: IZO
OTCQB: IZOZF
FSE: 1R3
Home
Investors
Stock Info
Financials
Presentation
Fact Sheet
Management
Advisors
Media
IzoView Images
Videos
News
Contact
Menu
Investors
Presentation
Investor Presentation
Stock Info
Financials
Presentation
Fact Sheet
Management
Advisors
Investors
Stock Info
Financials
Presentation
Fact Sheet
Management
Advisors
Media
IzoView Images
Videos
News
Izotropic Corporation Announces Non-Brokered Private Placement- November 2024
Izotropic Announces Regulatory Approval Plans to Launch IzoView for Breast Cancer Diagnostics in Patients with Dense Breasts in the U.S. and EU
Izotropic Amends Promissory Note Agreement With Primary Lender
Izotropic Announces Closing of First Tranche of Non-Brokered Private Placement
Izotropic Corporation Announces Non-Brokered Private Placement- June 2024
Izotropic Receives Response From U.S. FDA
Izotropic Provides Regulatory and Operational Updates
Izotropic Announces AGM Results- 2023
Izotropic Completes Pre-Submission Meeting With U.S. FDA
Izotropic Confirms FDA Pre-Submission Meeting Date
Izotropic Closes Non-Brokered Private Placement- September 2023
Izotropic Corporation Announces Non-Brokered Private Placement- September 2023
Izotropic Files Class II Pre-Submission with FDA & Releases Details On Predicate Devices
Izotropic Engages Market Awareness Consultant
Izotropic Modifies Market Approval Pathway & Strategy
Izotropic CEO Resigns
Izotropic Completes QSUB Meeting with FDA Regarding Clinical Study Acceleration
Izotropic Provides Business Update
Izotropic to Extend Period for Unsecured Loans
Izotropic’s Technical & Scientific Team Members Advocate for Commercialization of Breast CT Technology
Izotropic’s IzoView Breast CT Device To Be Featured On Advancements TV Show In USA
Izotropic Creates Compensation Committee and Adopts Charter
Izotropic Releases First Video of IzoView
Izotropic Reports Board Meeting Results
Izotropic Delays Announcements to 2023, Holds Board Meeting
Izotropic Announces 2022 AGM Results and Clarifies Restating of Financial Statements
Izotropic Corporation Files Amended and Restated Financial Statements For July 31, 2022
Izotropic Completes IzoView Development and Assembly, Prepares for Final Testing
Alexander Tokman Joins Izotropic Board of Directors
Izotropic Corporation Announces Closing Of Non-Brokered Private Placement- Nov 2022
Izotropic Grants Stock Options
Izotropic's IzoView is Weeks Away From Final Engineering & Showcasing to Investment and Scientific Communities
Izotropic Finalizes Engineering and Development Transition to The United States; Establishes Operations in Primary Target Market
Izotropic Engages Clinical Research Organization in Preparation for Clinical Study
Izotropic Reacts to Supply Chain Disruptions and Updates IzoView Engineering Timelines
Izotropic Unveils IzoView Commercial Prototype, Files New Patents
Izotropic Targets the Modern Investor and Engages Grit Capital
Izotropic Moves to Educate New Demographics On Breast CT, Engages New Consultants for Investor Relations & Awareness
Izotropic Announces Investor Conference Schedule
Izotropic Corporation Announces Closing of Non-Brokered Private Placement
Izotropic Corporation Announces Non-Brokered Private Placement
Breast CT Authority and Head of Clinical Trials Joins Izotropic
Izotropic Establishing Engineering and Development Facility in the USA
Izotropic Implements Quality Management System For Izoview Breast CT Device Manufacturing
Izotropic’s Breast CT Radiation Imaging Subsystem Powered On and Takes Initial Images
Izotropic Appoints Breast CT Expert As Head Of Imaging Technology
Izotropic Announces 2021 AGM Results
Izotropic Reaches Q3 Milestones and Provides Engineering Update
Izotropic Signs Agreement With Johns Hopkins University School of Medicine to Develop Deep Machine Learning Algorithms for IzoView Breast CT
Izotropic Nominated For Best New Radiology Device Award
Izotropic Receives Notice of Allowance For New 3D X-Ray Beam Filter Patent From USPTO
Izotropic Engages Consultants for Investor Relations and Dedicated Social Media and Communications Services
Izotropic Appoints Medical Device R&D Expert as Executive VP of Product Engineering
Izotropic Updates Timelines for Clinical Study and Fabrication of Initial Izoview Units
Izotropic Provides Corporate Update
Tomosynthesis Pioneer Joins Izotropic Scientific Advisory Board
Izotropic Accelerates Payor Engagement Activities with Excite International
Izotropic Launches Marketing Campaign
Izotropic Appoints Dr. John McGraw as Chief Executive Officer
Initial Insurance Billing Codes Issued for Dedicated Breast CT in the USA
Izotropic Launches New Website and Corporate Presentation
Izotropic Unveils “izoview” Branding For Breast CT Platform In Development And Files Trademark Applications
Izotropic Announces Upgrade to OTCQB Venture Market
Izotropic Grants Restricted and Performance Share Units
3D CT Imaging Expert Joins Izotropic Advisory
Izotropic Positioned to Execute in 2021
Izotropic Technology Founder Appointed Editor-In-Chief Of Medical Physics Journal
Izotropic Reports High Degree of Confidence After Pre-Submission Meeting With FDA
Izotropic Corporation Announces Closing of Non-Brokered Private Placement
Izotropic Cancels Options and Updates Amount of Broker Warrant Issued
Izotropic Engages Investor Relations and Market Awareness Consultants
Izotropic Corporation Announces Closing of Second Tranche of Non-Brokered Private Placement
Izotropic Unaware of Any Material Change
Izotropic Corporation Announces Non-Brokered Private Placement
Izotropic Announces 2020 AGM Results
Izotropic Announces Meeting Date With FDA
Mr. Alexander Tokman Joins Izotropic as Strategic Advisor
Izotropic Engages Marketsmart Communications
Izotropic Appoints Jaclyn Thast as Corporate Secretary
Izotropic Files Pre-Submission Application With U.S. FDA
Izotropic Unaware of Any Material Change
Izotropic Corporation Announces Adoption of Long Term Incentive Plan
Izotropic Engages Dr. Craig Abbey for Breast CT Reader Study Design
Izotropic Corporation Appoints Executive Vice President of Commercial Operations
Izotropic Engages Mr. James Berard for Investor Relation Services
Izotropic Corporation Announces Warrant Amendment
Izotropic Corporation Announces Issuance of Warrants Pursuant to January Warrant Incentive Program, Delayed Due to Covid-19
Izotropic Begins FDA Approval Process
FDA Consultant Joins Izotropic Advisory Board
Izotropic Engages Starfish Medical for Design and Development of Commercial Breast CT Model
Izotropic Announces Issuance of Patent to Use Breast CT for Robotic Guided Biopsy
Izotropic Announces Addition of George Burkett, M.Eng to Advisory Board
Izotropic Announces Issuance of Patent to Measure Breast Density With Breast CT Technology
Izotropic Provides Update on Globally Licensed Breast CT Technology
Izotropic Successfully Extends Exclusive Global License Agreement for Innovative Breast CT Technology Until 2027
Izotropic Receives Notice of Allowance for Measuring Breast Density From US Patent Office
Izotropic Corporation Announces Apppointment of Dr. John Mcgraw to Advisory Board
Izotropic Corporation Raises $1.23M From Warrant Exercise Program
Izotropic Corporation Receives Notice of Allowance From US Patent Office
Izotropic Corporation Announces Warrant Exercise Incentive Program
Izotropic Corporation Announces Cancellation and Issuance of Stock Options
What Could Google’s AI Capability Do with Real 3D Breast CT Images?
Contact
